Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
J Trop Pediatr ; 69(5)2023 09 07.
Article in English | MEDLINE | ID: mdl-37705261

ABSTRACT

INTRODUCTION: Congenital Zika syndrome (CZS) is a recently described disease. Our main objective was to evaluate and monitor, over 3 years, the ophthalmoscopic findings in children exposed to zika virus (ZIKV) during gestation. METHODS: This prospective observational study was conducted in Rio de Janeiro, Brazil, between April 2016 and May 2019. We evaluated two groups with exanthema serving as a proxy for viremia: (i) children whose mothers had exanthema during pregnancy and (ii) children who had microcephaly without maternal exanthema during pregnancy. We performed indirect ophthalmoscopy at recruitment and every 6 months thereafter. We also tested the association between ocular findings with maternal exanthema, microcephaly, CZS and maternal infection confirmed by reverse transcriptase quantitative polymerase chain reaction and gender. RESULTS: Of the 72 children included, 16 (22.2%) had optic nerve and/or retinal lesions. All 16 had CZS and 15 (93.7%) had microcephaly (14 at birth and 1 postnatally). The child with postnatally acquired microcephaly was born to a mother without exanthema during pregnancy. Fifty-six (77.8%) of the 72 children were followed for a median time of 24 months and none exhibited differences between admission and follow-up examinations. After logistic regression, only microcephaly at birth was associated with eye abnormalities (odds ratio, 77.015; 95% confidence interval, 8.85-670.38; p < 0.001). CONCLUSION: We observed that there was no progression of the lesions over the follow-up period. We also showed that the eye findings were associated only with microcephaly at birth. Attention should be paid to all children born during a ZIKV epidemic, regardless of maternal exanthema and/or microcephaly at birth.


Subject(s)
Exanthema , Microcephaly , Zika Virus Infection , Zika Virus , Infant, Newborn , Female , Pregnancy , Child , Humans , Zika Virus/genetics , Zika Virus Infection/diagnosis , Zika Virus Infection/epidemiology , Microcephaly/epidemiology , Follow-Up Studies , Brazil/epidemiology , Exanthema/etiology , Mothers
2.
J Pediatr ; 256: 27-32, 2023 05.
Article in English | MEDLINE | ID: mdl-36470461

ABSTRACT

OBJECTIVE: To assess the clinical and radiographic characteristics of hip joint deformities in children with congenital Zika syndrome (CZS), and the evolution of hip joint deformities in affected infants for the first 3 years of life. STUDY DESIGN: This prospective observational study evaluated orthopedic clinical examinations performed every 3 months to assess hip flexion and extension, lateral and medial rotation, and abduction and adduction, as well as lower limb muscle length and tone. The biannual radiograph comprised anteroposterior panoramic pelvic radiographs with the lower limbs in extension. Percentage of migration was used as a radiographic study tool to measure and evaluate linear hip displacement. RESULTS: From November 2018 to March 2020, we followed 30 children with CZS, of whom 15 (50%) had normal pelvic radiographs on admission; 5 (33.3%) developed hip displacement by the second radiograph examination. During follow-up radiographic examinations, 20 of the 30 children (66.7%) were diagnosed with hip displacement and/or dislocation of at least 1 side, and 10 of the 30 (33.3%) remained normal. Among 30 affected patients, 13 (43.3%) had hip displacement on the right side and 9 (30%) on the left side. Logistic regression analysis revealed that spasticity (P = .0033; OR, 15.9) and ophthalmologic abnormalities (P = .0163; OR, 16.9) were associated with hip dislocation during follow-up. CONCLUSIONS: Pelvic radiographic follow-up for all children with CZS will complement physical examination, diagnosis, and monitoring for hip joint deformities.


Subject(s)
Hip Dislocation , Zika Virus Infection , Zika Virus , Infant , Humans , Child , Hip Dislocation/diagnostic imaging , Zika Virus Infection/complications , Zika Virus Infection/diagnosis , Hip Joint/diagnostic imaging , Radiography , Pelvis
3.
Braz J Microbiol ; 53(4): 1959-1967, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36149627

ABSTRACT

The use of oral fluid (OF) samples for serological diagnosis of parvovirus B19 infection during outbreaks of erythema infectiosum had already been demonstrated, but the feasibility of using OF for the characterization of B19 genotypes circulating during outbreaks has not been described. The aim of this study was to assess the use of "in-house" PCR-based assays as a powerful tool for a rapid diagnosis and molecular characterization of B19 strains in OF samples during outbreaks. Paired serum and OF samples collected from anti-B19 IgM-positive patients, during two outbreaks of ertythema infectiosum (1999-2000 and 2004-2005), were tested by conventional (cPCR) and quantitative PCR (qPCR). qPCR was more sensitive than cPCR for detecting B19-DNA in both OF and serum. Overall, OF presented lower viral load (9.97 × 106 UI/mL) than serum (2.42 × 1010 UI/mL) and this difference was statistically significant. All OF samples obtained from patients in the age group < 14 years presented low viral load (< 104 IU/mL). No correlation was found between viral load and the number of days of onset of rash. Sequence analysis from PCR positive OF samples confirmed the circulation of subgenotype 1a (G1a) during these outbreaks. Our findings indicate that PCR-based assays may fail to detect B19-DNA in approximately 50% of OF compared to serum samples. Nevertheless, our study has shown for the first time that the genome sequence of the amplicon from non-invasive clinical sample is useful for molecular genotyping and may be a tool to clarify the genetic diversity of B19 strains circulating in distinct outbreaks.


Subject(s)
Erythema Infectiosum , Parvovirus B19, Human , Humans , Adolescent , Erythema Infectiosum/epidemiology , Erythema Infectiosum/diagnosis , Parvovirus B19, Human/genetics , DNA, Viral/genetics , DNA, Viral/analysis , Disease Outbreaks , Real-Time Polymerase Chain Reaction , Antibodies, Viral
4.
Eur J Pediatr ; 181(3): 991-999, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34661750

ABSTRACT

The aim of the study was to describe neurological manifestations in children with congenital Zika syndrome (CZS) in the first 2 years of age. In this prospective observational study, children with CZS treated at a university hospital received a neurological assessment and were evaluated using two neurodevelopmental scales (the Denver II test and the assessment of gross motor development of the World Health Organization) by a pediatric neurologist on admission to the study and at 4, 8, 12, 18, and 24 months of age. The data collected were stored in Microsoft Excel version 14.6.3. Thirty-eight children (27 males and 11 females; a median age of 4.3 months (interquartile range (IQR): 1.6-11.4)) with CZS were evaluated. Irritability was present in 50% and 27% of the children at 8 months and 24 months, respectively. Axial hypertonia was highly prevalent at 4 months (77%), with a decrease to 50% at 24 months. At all ages, spastic tetraparesis was the most common motor abnormality (> 80%). Twenty-seven (71%) participants were diagnosed with epilepsy, and the median age at seizure onset was 6 months (IQR: 3.5-8). The most frequent types of seizures were focal seizures and spasms, with spasms being the most frequent in the first year of life (52%) and focal crises being the most frequent in the second year of life (50%).Conclusion: This study allowed observation of neurological abnormalities over time, the evolution of epileptic manifestations, and recognition of new patterns of clinical neurological abnormalities, helping clinicians to recognize CZS earlier, minimizing the impact of new outbreaks. What is Known: • Clinical patterns of SZC patients at pre-established ages or date of data collection • More frequent studies with data collection of clinical-radiological features of patient's over his first year of life What is New: • Comprehensive clinical neurological progression data regarding CZS in the first 2 years of life, recognizing patterns • Hypothesis including a new CZS spectrum with milder clinical-radiological features.


Subject(s)
Epilepsy , Microcephaly , Pregnancy Complications, Infectious , Zika Virus Infection , Zika Virus , Brazil/epidemiology , Child , Epilepsy/epidemiology , Female , Follow-Up Studies , Humans , Infant , Male , Microcephaly/epidemiology , Microcephaly/etiology , Pregnancy , Prospective Studies , Zika Virus Infection/complications , Zika Virus Infection/diagnosis , Zika Virus Infection/epidemiology
5.
Front Immunol ; 12: 610456, 2021.
Article in English | MEDLINE | ID: mdl-33679748

ABSTRACT

Background: Zika virus (ZIKV) infection causes for mild and self-limiting disease in healthy adults. In newborns, it can occasionally lead to a spectrum of malformations, the congenital Zika syndrome (CZS). Thus, little is known if mothers and babies with a history of ZIKV infection were able to develop long-lasting T-cell immunity. To these issues, we measure the prevalence of ZIKV T-cell immunity in a cohort of mothers infected to the ZIKV during pregnancy in the 2016-2017 Zika outbreak, who gave birth to infants affected by neurological complications or asymptomatic ones. Results: Twenty-one mothers and 18 children were tested for IFN-γ ELISpot and T-cell responses for flow cytometry assays in response to CD4 ZIKV and CD8 ZIKV megapools (CD4 ZIKV MP and CD8 ZIKV MP). IFN-γ ELISpot responses to ZIKV MPs showed an increased CD4 and CD8 T-cell responses in mothers compared to children. The degranulation activity and IFN-γ-producing CD4 T cells were detected in most mothers, and children, while in CD8 T-cells, low responses were detected in these study groups. The total Temra T cell subset is enriched for IFN-γ+ CD4 T cells after stimulation of CD4 ZIKV MP. Conclusion: Donors with a history of ZIKV infection demonstrated long-term CD4 T cell immunity to ZIKV CD4 MP. However, the same was not observed in CD8 T cells with the ZIKV CD8 MP. One possibility is that the cytotoxic and pro-inflammatory activities of CD8 T cells are markedly demonstrated in the early stages of infection, but less detected in the disease resolution phase, when the virus has already been eliminated. The responses of mothers' T cells to ZIKV MPs do not appear to be related to their children's clinical outcome. There was also no marked difference in the T cell responses to ZIKV MP between children affected or not with CZS. These data still need to be investigated, including the evaluation of the response of CD8 T cells to other ZIKV peptides.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Immunologic Memory , Zika Virus Infection/immunology , Zika Virus/immunology , Adult , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , CD8-Positive T-Lymphocytes/metabolism , Cross Reactions/immunology , Cross-Sectional Studies , Female , Humans , Immunity, Maternally-Acquired , Immunophenotyping , Neutralization Tests , Pregnancy , Pregnancy Complications, Infectious , Young Adult , Zika Virus Infection/blood , Zika Virus Infection/epidemiology
6.
Multidiscip Respir Med ; 15(1): 692, 2020 Jan 28.
Article in English | MEDLINE | ID: mdl-33117533

ABSTRACT

BACKGROUND: Influenza A (H1N1) virus often compromises the respiratory tract, leading to pneumonia, which is the principal cause of death in these patients. The purpose of this study was to review the acute and late phase pulmonary findings in influenza A(H1N1) associated pneumonia using high resolution computed tomography (HRCT), and to determine the importance of performing end expiration series. METHODS: Between July and August 2009, 140 patients presented with influenza A (H1N1) confirmed by real-timepolymerase chain reaction. Out of these, 27 patients underwent HRCT in the acute and late phases of pneumonia, allowing for a comparative study. Late phase exams were performed due to clinical worsening and up to 120 days later in patients with persistent complaints of dyspnea. RESULTS: Ground glass opacities, consolidations, and the combination of both were associated with the acute phase, whereas persistence or worsening of the lesions, lesion improvement, and air trapping in the end expiration series (as seen using HRCT, n=6) were observed in the late phase. CONCLUSIONS: In the HRCT end expiration series, air trapping was found in the late phase of H1N1 associated pneumonia. Generally, these exams are not evaluated in research articles, and air trapping has not previously been studied using the end expiration series. Our study brings more scientific knowledge about aspects of pulmonary involvement by influenza A (H1N1), through evaluation with end expiration series, which makes the CT exam dynamic, translating the respiratory movement, and showing bronchial alteration.

7.
Acta Trop ; 206: 105438, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32165128

ABSTRACT

INTRODUCTION: Typical symptoms of primary Zika virus infection are not specific and share similarities with other arbovirus infections such as dengue fever and chikungunya. As acute infection can be asymptomatic in up to 73% of cases, infants with microcephaly represent a diagnostic challenge for pediatricians. We describe the frequency of congenital Zika syndrome (CZS) in Brazilian children born to asymptomatic pregnant mothers and its differential diagnosis. METHODS: This longitudinal, observational study was conducted on children with suspected CZS whose mothers did not report rash during pregnancy, referred to the reference hospital in a metropolitan area of ​ Rio de Janeiro, Brazil. The diagnosis of suspected CZS was based on Brazilian Ministry of Health protocol. RESULTS: Forty-three (17%) of 246 referred children were born to mothers without rash history during pregnancy. Thirteen (30%) of 43 children met the Brazilian Ministry of Health criteria for CZS, all with microcephaly (two post-natal). The other children included 11 cases with post-natal microcephaly due to hypoxic-ischemic encephalopathy (6), non-progressive encephalopathy of unknown etiology (2), microcephaly under investigation (2) and congenital toxoplasmosis (1); 17 children were misdiagnosed with microcephaly and progressed with normal head circumference during the follow-up period; one child was included because of epidemiological link and one was loss to follow-up. All children who underwent laboratory investigation for ZIKV infection during neonatal period had negative RT-qPCR tests. CONCLUSION: We emphasize the increasing importance of CZS in differential diagnosis of microcephaly at birth or post-natal period. Detailed clinical investigation assisted by neuroimaging tests may clarify the diagnosis of CZS when laboratory tests are not available during the acute phase of the disease.


Subject(s)
Microcephaly/diagnosis , Pregnancy Complications, Infectious , Zika Virus Infection/congenital , Zika Virus Infection/diagnosis , Adult , Asymptomatic Infections , Diagnosis, Differential , Female , Humans , Infant , Longitudinal Studies , Pregnancy
8.
Lung ; 195(4): 389-395, 2017 08.
Article in English | MEDLINE | ID: mdl-28612239

ABSTRACT

Dengue fever is an arboviral disease transmitted to humans through the bites of infected female Aedes mosquitoes. Dengue virus is a member of the Flaviviridae family, and human infection can be caused by any of the four antigenically distinct serotypes (DENV 1-4). The infection has become recognized as the most important and prevalent arboviral disease in humans, endemic in almost 100 countries worldwide. Nearly 3 billion people live in areas with transmission risk. Autochthonous transmission of the virus in previously disease-free areas, increased incidence in endemic areas, and epidemic resurgence in controlled regions could increase the risk of contracting more severe forms of the disease, such as dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Symptomatic dengue virus infection can present with a wide range of clinical manifestations, from mild fever to life-threatening DSS. Thoracic complications may manifest as pleural effusion, pneumonitis, non-cardiogenic pulmonary edema, and hemorrhage/hemoptysis. No vaccine is currently available and no specific treatment for dengue fever exists, but prevention and prompt management of complications in patients with DHF can help reduce mortality. This review describes the main clinical, pathological, and imaging findings of thoracic involvement in DHF.


Subject(s)
Aedes/virology , Dengue Virus/pathogenicity , Hemoptysis/virology , Lung/virology , Severe Dengue/virology , Animals , Biopsy , Dengue Vaccines/therapeutic use , Diagnosis, Differential , Hemoptysis/diagnosis , Hemoptysis/mortality , Hemoptysis/therapy , Humans , Lung/diagnostic imaging , Lung/pathology , Predictive Value of Tests , Prognosis , Risk Factors , Severe Dengue/diagnosis , Severe Dengue/mortality , Severe Dengue/therapy , Tomography, X-Ray Computed
9.
Acta Trop ; 149: 138-47, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25944351

ABSTRACT

Dengue fever is usually a benign acute viral infection transmitted by arthropods but may evolve to severe clinical manifestations such as coagulation and/or hemodynamic disorders, caused mainly by an increase of vascular permeability. Deregulated circulating immunological factors have been associated with severity. In Brazil severe cases appeared in children only recently and we evaluated the profile of cytokine/chemokine kinetics in 134 hospitalized young patients during the epidemic in Rio de Janeiro in 2008. Inflammatory cytokines TNF and IFNγ were found elevated during the acute phase in children as well as the anti-inflammatory IL10 and chemokines MIF and CXCL10/IP10, all last three persisting longer during the recovery phase. Severe disease fitting the dengue hemorrhagic fever pattern (WHO, 1997) was associated with higher IL10 and CXCL10/IP10 circulating levels (peak levels at seven days with P<0.01 and P<0.001 respectively as compared to DF). These factors were higher in patients pulmonary effusion or ascites (P<0.05 for IL10 and P<0.01 for CXCL10/IP10). Both factors were also associated with liver changes such as AST increase correlated with CXCL10/IP10 (r=0.4300 with P<0.0001) and patients presenting painful hepatomegaly showed higher circulating levels of IL10 (P<0.01, at 7-9 days) and of CXCL10/IP10 (P<0.05, 4-6 days and P<0.001, 7-9 days) when compared to patients without apparent liver alterations. Most cases presented a history of prior infection (93%). This is the first study demonstrating cytokine and chemokine association with severity during dengue fever in Brazilian children. IL10 and CXCL10/IP10 play a role in the disease severity associated with induction of vascular leakage and a novel association with changes in liver dysfunction.


Subject(s)
Capillary Permeability/immunology , Chemokines/immunology , Epidemics , Liver Diseases/immunology , Severe Dengue/immunology , Acute Disease , Adolescent , Alanine Transaminase/metabolism , Ascites/etiology , Ascites/immunology , Aspartate Aminotransferases/metabolism , Brazil/epidemiology , Chemokine CXCL10/immunology , Child , Child, Preschool , Cohort Studies , Cytokines/immunology , Dengue/complications , Dengue/epidemiology , Dengue/immunology , Female , Hepatomegaly/etiology , Hepatomegaly/immunology , Humans , Infant , Interferon-gamma/immunology , Interleukin-10/immunology , Interleukin-13/immunology , Intramolecular Oxidoreductases/immunology , Liver Diseases/etiology , Liver Diseases/metabolism , Macrophage Migration-Inhibitory Factors/immunology , Male , Pleural Effusion/etiology , Pleural Effusion/immunology , Retrospective Studies , Severe Dengue/complications , Severe Dengue/epidemiology , Tumor Necrosis Factor-alpha/immunology
10.
Infect Genet Evol ; 20: 197-205, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24016730

ABSTRACT

Dengue is an arthropod-borne emerging viral disease with high morbidity and mortality risk in tropical countries like Brazil. Clinical manifestations are vast, ranging from asymptomatic to most severe forms of dengue such as shock. Previous data have shown that host genetics play a role in disease susceptibility and severity. Herein, we have tested the association of single nucleotide polymorphisms (SNPs) at TNF, IL10, MIF, DCSIGN, CLEC5A, NOD2, CCR5 and MRC1 as candidate genes using a matched case-control study design including 88 severe children cases of dengue patients and 335 healthy unrelated subjects that was also separated in IgG(+) and IgG(-) controls. We demonstrated that the TT genotype of CLEC5A SNP (rs1285933 C>T) is associated with dengue severity (OR=2.25; p=0.03) and that GG genotype of -336G>A DCSIGN (CD209) SNP is associated with protection to severe dengue (OR=0.12; p=0.04). Both comparisons were borderline significant when cases were compared with IgG(+) controls subgroup. Nevertheless, genotype-phenotype correlation was also assessed using serum levels of TNF from infected patients at the onset of dengue fever, and CT/TT carriers in CLEC5A secreted higher levels of TNF than CC individuals in 5-7 days of infection. No significant difference was observed in TNF levels between genotypes GG versus AG/AA at DCSIGN promoter. Next, we performed a meta-analysis retrieving results from the literature for -336G>A DCSIGN and -308G>A TNF SNPs demonstrating that the consensus estimates of these SNPs indicated no association with dengue severity (when compared to Dengue fever) in the overall analysis. But, a subgroup analysis in the -336G>A DCSIGN, the G allele was associated with severe dengue susceptibility in Asians (ORallele=2.77; p=0.0001; ORcarriers=2.99; p=0.0001) and protection in Brazilians (ORallele=0.66; p=0.013). In summary, our results suggest that genetic variations at CLEC5A increase the risk and regulate TNF secretion in dengue severity among Brazilians. Also, combined data of the literature suggest population-specific effect of the -336 DCSIGN SNP more prominent in Asians and in a different direction than Brazilians.


Subject(s)
Cell Adhesion Molecules/genetics , Dengue Virus/immunology , Dengue/genetics , Dengue/immunology , Lectins, C-Type/genetics , Receptors, Cell Surface/genetics , Case-Control Studies , Child , Female , Gene Frequency , Genetic Predisposition to Disease , Genetic Variation , Genotype , Humans , Inflammation/genetics , Inflammation/immunology , Male , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , Risk , Tumor Necrosis Factor-alpha/blood
11.
Mem Inst Oswaldo Cruz ; 107(3): 356-61, 2012 May.
Article in English | MEDLINE | ID: mdl-22510831

ABSTRACT

Erythrovirus B19 (B19V) infection may cause red cell aplasia in patients infected with human immunodeficiency virus (HIV). The introduction of highly active antiretroviral therapy (HAART) has improved the immune function of these patients by modifying the course of B19V infection. The purpose of this study was to estimate the frequency of B19 seroconversion in a cohort of HIV-infected patients and evaluate the occurrence of B19V-related anaemia during the seroconversion period. Adult HIV-infected patients were studied at a public hospital in Niterói, state of Rio de Janeiro, Brazil. IgG and IgM antibodies against B19V were detected by an enzyme-linked immunosorbent assay and B19 viraemia was assayed by polymerase chain reaction. Medical records were reviewed for any clinical evaluation of anaemia. Seroconversion was detected in 31.8% of the 88 individuals who began the study as anti-B19V IgG-negative. No clinical manifestations of B19V infection were detected during the period of seroconversion. Patients who seroconverted were 5.40 times more likely to have anaemia than those who did not [odds ratio 5.40 (95% confidence interval: 1.33-22.93)]. Anaemia was detected in eight patients. All patients recovered from anaemia by either beginning or continuing HAART, without requiring blood transfusions. In the HAART era, B19V infection may only be associated with a course of disease characterised by less severe chronic anaemia. This milder course of B19V-associated disease is likely due to the increased immune function of HAART-treated patients.


Subject(s)
AIDS-Related Opportunistic Infections/immunology , Anemia/virology , Antibodies, Viral/blood , Parvoviridae Infections/immunology , Parvovirus B19, Human/immunology , Adult , Antiretroviral Therapy, Highly Active , DNA, Viral/analysis , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Polymerase Chain Reaction
12.
PLoS One ; 7(3): e33754, 2012.
Article in English | MEDLINE | ID: mdl-22448271

ABSTRACT

This 15-year study aimed to determine the role of the main viruses responsible for acute infantile gastroenteritis cases in a day care center in the city of Rio de Janeiro, Brazil. From 1994 to 2008, 539 fecal samples were obtained from 23 outbreaks as well as sporadic cases that occurred in this period. The detection of Rotavirus group A (RVA), norovirus (NoV) and astrovirus (AstV) was investigated both by classical and molecular methods of viral detection. RVA was detected by enzymatic immune assay and/or polyacrylamide gel electrophoresis and genotyped by using semi-nested multiplex PCR. NoV and AstV were subsequently tested by real time PCR in all RVA-negative samples and genotyped throughout genome sequencing. Three protocols for molecular characterization of NoV nucleotide sequencing were performed with the partial nucleotide sequencing of genomic regions known as region B (polymerase gen), C and D (capsid gen).Viruses were identified in 47.7% (257/539) of the cases, and the detection rates of RVA, NoV and AstV in16.1% (87/539), 33.4% (151/452), and 6.3% (19/301), respectively. Most gastroenteritis cases were reported in autumn and winter, although NoV presented a broader monthly distribution. Viruses' detection rates were significantly higher among children aged less than 24 months old, although NoV cases were detected in all age groups. RVA genotypes as G1P[8], G9P[8], G2P[4], G3P[8] and G1+G3P[8] and RVA was no longer detected after 2005. NoV characterization revealed genotypes variability circulating in the period as GI.2, GI.3, GI.8 GII.2, GII.3, GII.4, GII.4 variants 2001 and 2006b, GII.6, GII.7, GII.12 and GII.17. AstV genotypes 1, 2, 4 and 5 were also characterized. Those data demonstrate the impact of NoV infection in cases of infantile gastroenteritis, surpassing RVA infection responsible for high morbidity rate in children under five years old.


Subject(s)
Astroviridae Infections/diagnosis , Caliciviridae Infections/diagnosis , Child Day Care Centers , Gastroenteritis/epidemiology , RNA, Viral/genetics , Rotavirus Infections/diagnosis , Adult , Astroviridae Infections/genetics , Astroviridae Infections/virology , Brazil/epidemiology , Caliciviridae Infections/genetics , Caliciviridae Infections/virology , Child, Preschool , Feces/virology , Follow-Up Studies , Gastroenteritis/genetics , Gastroenteritis/virology , Humans , Incidence , Infant , Mamastrovirus/genetics , Mamastrovirus/isolation & purification , Molecular Epidemiology , Norovirus/genetics , Norovirus/isolation & purification , Real-Time Polymerase Chain Reaction , Rotavirus/genetics , Rotavirus/isolation & purification , Rotavirus Infections/genetics , Rotavirus Infections/virology
13.
Mem Inst Oswaldo Cruz ; 107(8): 1064-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23295760

ABSTRACT

This retrospective study (April-September 2003) was designed to investigate the roles of the main viruses responsible for cases of acute infantile gastroenteritis in hospitalised children up to two years of age. The viruses were identified in 64.7% (88/136) of the cases and the detection rates of rotavirus A (RVA), norovirus (NoV) and astrovirus were 41.9% (57/136), 30.3% (24/79) and 12.7% (7/55), respectively. RVA and NoV were detected in 20 of the 24 reported nosocomial infection cases. This study identified the first circulation of the genotype NoV GII.21 in Brazil and highlights the need to establish differential diagnoses through active laboratorial surveillance.


Subject(s)
Gastroenteritis/virology , Mamastrovirus/genetics , Norovirus/genetics , Rotavirus/genetics , Acute Disease , Brazil , Feces/virology , Female , Genotype , Hospitalization , Humans , Infant , Infant, Newborn , Male , Mamastrovirus/isolation & purification , Norovirus/isolation & purification , Retrospective Studies , Rotavirus/isolation & purification , Seasons
14.
Clin Rheumatol ; 28(9): 1067-71, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19415376

ABSTRACT

The aim of this study was to assess the association of acute arthropathy and selected clinical features in patients with acute rash diseases. Serum samples from 1,554 patients were tested for anti-measles, dengue, human parvovirus B19, and rubella virus IgM using enzyme immunoassay. Sera from children, in whom these infections were excluded, were studied for anti-human herpesvirus type 6 IgG antibodies using an indirect immunofluorescence test. Joint complaints occurred in 31.2% of the 862 patients with an etiologic diagnosis and were more frequently seen in adults than in children (OR 8.5). Among the adults, arthropathy prevailed in women compared to men (OR 1.8). Arthropathy was most frequently reported in rubella (41.2%) and in dengue fever cases (41.1%) than in the other rash diseases studied (p < 0.0001). Joint complaints were more frequently seen in patients with fever (OR 1.6) and with five or more days of onset of the disease (OR 1.6), regardless of serological diagnosis. Arthropathy appeared as a frequent condition in rash diseases, typically with low severity and no specific pattern of joint involvement.


Subject(s)
Antibodies, Viral/blood , Exanthema/epidemiology , Exanthema/virology , Joint Diseases/epidemiology , Joint Diseases/virology , Virus Diseases/epidemiology , Acute Disease , Adult , Child , Dengue/epidemiology , Dengue/immunology , Dengue Virus/immunology , Exanthema/immunology , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Infant, Newborn , Joint Diseases/immunology , Male , Measles/epidemiology , Measles/immunology , Measles virus/immunology , Parvoviridae Infections/epidemiology , Parvoviridae Infections/immunology , Parvovirus B19, Human/immunology , Rubella/epidemiology , Rubella/immunology , Rubella virus/immunology , Seroepidemiologic Studies , Virus Diseases/immunology
15.
J Virol Methods ; 153(2): 273-5, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18703091

ABSTRACT

Human herpesvirus 6 (HHV-6) has been shown to infect almost all children by 4 years of age. Even with a typical clinical presentation, HHV-6 infection is misdiagnosed frequently as measles or rubella. The aim of this study was to assess the accuracy of the IgM test for detection of recent primary HHV-6 infection. The study was conducted between January, 1998 and December, 2006 at primary health care units in Niterói, Rio de Janeiro, Brazil. Sera from 185 children, in whom measles, rubella, dengue fever and parvovirus B19 infections were excluded, were studied for anti-HHV-6 IgG and IgM antibodies using an indirect immunofluorescence test. Seventy-one (38.4%) of the children had evidence of primary HHV-6 infection. Taking the IgG avidity test as the "gold standard", the following results for IgM were obtained-sensitivity: 76.1%; specificity: 87.5%; accuracy: 82.4%. This study confirmed the low accuracy of IgM detection for the diagnosis of primary HHV-6 infection.


Subject(s)
Herpesvirus 6, Human/immunology , Immunoglobulin M/blood , Roseolovirus Infections/diagnosis , Antibodies, Viral/blood , Brazil , Child, Preschool , Fluorescent Antibody Technique, Indirect , Humans , Immunoglobulin G/blood , Reproducibility of Results , Roseolovirus Infections/immunology , Roseolovirus Infections/virology , Sensitivity and Specificity
16.
Pediatr Infect Dis J ; 27(6): 533-7, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18449066

ABSTRACT

BACKGROUND: Human herpesvirus type 6 (HHV-6) has been shown to infect almost all children by 4 years of age. Primary infection causes an undifferentiated febrile illness, with approximately 30% of children exhibiting the classic clinical manifestations of exanthem subitum. Even with typical clinical presentation, exanthem subitum is frequently misdiagnosed as measles or rubella. Our aim was to describe the frequency and clinical manifestations of HHV-6 infection in children less than 4 years of age enrolled in a study designed to define the etiology of rash diseases. PATIENTS AND METHODS: The study was conducted between January 1998 and December 2006 at a general hospital and a large primary health care unit from Niterói, Rio de Janeiro, Brazil. Sera from 223 children, in whom measles, rubella, dengue fever, and parvovirus B19 infections were excluded, were studied for anti-HHV-6 antibodies using an indirect immunofluorescence test. Demographic and clinical data of those patients were described. RESULTS: Ninety-seven (43.5%) of the children had evidence of primary HHV-6 infection. The age of onset peaked at 6-11 months and 75% of the HHV-6 infection occurred in children between 6 and 17 months. Only 21% of the HHV-6 cases had a typical roseola-like illness and 73% and 46%, respectively, fulfilled the clinical criteria of measles and rubella suspected case. CONCLUSIONS: Our study confirms the importance of HHV-6 infection in young children and highlights the difficulties of diagnosing a rash illness on clinical grounds alone.


Subject(s)
Exanthema Subitum/epidemiology , Exanthema Subitum/virology , Herpesvirus 6, Human/isolation & purification , Roseolovirus Infections/epidemiology , Roseolovirus Infections/virology , Antibodies, Viral/blood , Brazil/epidemiology , Child, Preschool , Exanthema Subitum/diagnosis , Female , Fluorescent Antibody Technique, Indirect , Humans , Infant , Male , Measles/diagnosis , Roseolovirus Infections/diagnosis , Rubella/diagnosis , Seroepidemiologic Studies
17.
Mem Inst Oswaldo Cruz ; 101(4): 407-14, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16951812

ABSTRACT

Erythrovirus B19 infects erythrocytic progenitors, transiently interrupting erythropoiesis. In AIDS patients it causes chronic anemia amenable to treatment. We looked for evidences of B19 infection in stored bone marrow material from patients with acquired immunodeficiency syndrome. Histological sections were made from stored paraffin blocks from 33 autopsies (39 blocks) and 35 biopsies (45 blocks, 30 patients) performed from 1988 to 2002. They were examined after hematoxylin-eosin (HE) staining, immunohistochemical (IHC), and in situ hybridization. HE revealed intra-nuclear inclusion bodies ("lantern cells") suggesting B19 infection in 19 sections corresponding to 19 of 63 patients examined with this test. Seven of 78 sections subjected to immunohistochemistry were positive, corresponding to 7 of 58 patients examined with this test. Fourteen sections corresponding to 13 of the 20 HE and/or IHC positive patients were subjected to in situ hybridization, with six positives results. Among the 13 patients subjected to the three techniques, only one gave unequivocal positive results in all and was considered a true positive. The frequency of B19 infection (1/63 patients) in the material examined can be deemed low.


Subject(s)
AIDS-Related Opportunistic Infections/diagnosis , Bone Marrow/virology , Parvoviridae Infections/diagnosis , Parvovirus B19, Human/isolation & purification , AIDS-Related Opportunistic Infections/pathology , AIDS-Related Opportunistic Infections/virology , Biopsy , Bone Marrow/pathology , Bone Marrow Examination/methods , Eosine Yellowish-(YS) , Female , Hematoxylin , Humans , Immunohistochemistry , In Situ Hybridization , Male , Paraffin Embedding , Parvoviridae Infections/pathology , Parvoviridae Infections/virology
18.
Mem Inst Oswaldo Cruz ; 101(3): 315-9, 2006 May.
Article in English | MEDLINE | ID: mdl-16862329

ABSTRACT

This study was designed to determine the seroprevalence of herpes simplex virus type 2 (HSV-2) and to evaluate its association with age, sex as well as other demographic and behavioural factors in 150 human immunodeficiency virus (HIV) positive adults patients attending the general medical outpatient ward for routine care of Niterói, state of Rio de Janeiro, Brazil. Serum samples were screened for HSV-2 antibodies using an indirect ELISA. Eighty-three patients were men (mean age: 38.8) and 67 were women (mean age: 35.4). The estimated prevalence of HSV-2 was 52% (95% CI: 44-60%) and it was higher among men (53%) than among women (50.7%). Overall, the age of first sexual intercourse and past history of genital herpes were associated with HSV-2 seropositivity. Analysis by gender disclosed significant association of number of lifetime sex partners only among men. Although HSV-2 antibodies were frequent in the study group, genital herpes was reported by 21.8% of the HSV-2 positive subjects, indicating low awareness of the HSV-2 infection. These results may have public health importance for Brazil as the high rate of HSV-2 infection may act as a cofactor of HIV transmission.


Subject(s)
Antibodies, Viral/blood , HIV Infections/complications , Herpes Genitalis/epidemiology , Herpesvirus 2, Human/immunology , Immunoglobulin G/blood , Adult , Brazil/epidemiology , CD4 Lymphocyte Count , Enzyme-Linked Immunosorbent Assay , Female , Herpes Genitalis/complications , Herpes Genitalis/diagnosis , Humans , Male , Middle Aged , Prevalence , Risk Factors , Seroepidemiologic Studies , Sexual Behavior
19.
Rev Saude Publica ; 40(3): 450-6, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16810369

ABSTRACT

OBJECTIVE: To assess the performance of the rubella suspect case definition among patients with rash diseases seen at primary care units. METHODS: From January 1994 to December 2002, patients with acute rash, with or without fever, were seen at two large primary health care units and at a public general hospital in the municipality of Niterói, metropolitan area of Rio de Janeiro, Brazil. Data from clinical and serologic assessment were used to estimate the positive predictive values of the definition of rubella suspect case from the Brazilian Ministry of Health and other combination of signs/symptoms taking serologic status as the reference. Serum samples were tested for anti-rubella virus IgM using commercially available enzyme immunoassays. Positive predictive values and respective 95% confidence intervals were calculated. RESULTS: A total of 1,186 patients with an illness characterized by variable combinations of rash with fever, arthropathy and lymphadenopathy were studied. Patients with rash, regardless of other signs and symptoms, had 8.8% likelihood of being IgM-positive for rubella. The Brazilian suspect case definition (fever and lymphadenopathy in addition to rash) had low predictive value (13.5%). This case definition would correctly identify 42.3% of the IgM-positive cases, and misclassify 26.1% of the IgM-negative cases. CONCLUSIONS: These results support the recommendation to investigate and collect clinical specimens for laboratory diagnosis of all cases of rash, for surveillance purposes. Although this strategy may increase costs, the benefits of interrupting the circulation of rubella virus and preventing the occurrence of congenital rubella syndrome should pay off.


Subject(s)
Antibodies, Viral/blood , Immunoglobulin M/blood , Rubella virus/immunology , Rubella/diagnosis , Brazil , Cross-Sectional Studies , Female , Humans , Immunoenzyme Techniques , Male , Population Surveillance , Predictive Value of Tests , Reagent Kits, Diagnostic , Sensitivity and Specificity
20.
Mem Inst Oswaldo Cruz ; 99(1): 95-9, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15057355

ABSTRACT

Erythrovirus B19 infection is usually benign but may have serious consequences in patients with hemolytic anemia (transient aplastic crisis), immunodeficiency (in whom persistent infection can lead to chronic bone marrow failure with anemia), or who are in the first or second trimester of gestation (spontaneous abortion, hydrops fetalis, and fetal death). Being non-enveloped, B19 resists most inactivation methods and can be transmitted by transfusion. B19 is difficult to cultivate and native virus is usually obtained from viremic blood. As specific antibodies may be absent, and there is no reliable immunological method for antigen detection, hybridization or polymerase chain reaction are needed for detecting viremia. A rapid method, gel hemagglutination (Diamed ID-Parvovirus B19 Antigen Test), can disclose highly viremic donations, whose elimination lessens the viral burden in pooled blood products and may even render them non-infectious. In order to obtain native antigen and to determine the frequency of viremic donors, we applied this test to blood donors in a period of high viral activity in our community. Positive or indeterminate results were re-tested by dot-blot hybridization. We tested 472 donors in 1998 and 831 ones in 1999. One viremic donor was found in 1999. We suggest that in periods of high community viral activity the gel hemagglutination test may be useful in avoiding highly viremic blood being added to plasma pools or directly transfused to patients under risk.


Subject(s)
Antigens, Viral/isolation & purification , Blood Donors , Parvoviridae Infections/diagnosis , Parvovirus B19, Human/immunology , Viremia/diagnosis , Brazil , Female , Hemagglutination Tests/methods , Hemagglutination, Viral , Humans , Male , Viremia/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...